Document is current
Any future updates will be listed below
-
Authors
Zhou, Mengping
Larsson, Henrik
D’Onofrio, Brian M.
Landén, Mikael
Lichtenstein, Paul
Pettersson, Erik
-
Funding
Funding for this research was provided by:
Swedish Research Council (2017-01358)
Swedish Research Council for Health, Working Life and Welfare (2023-00402)
Svenska Läkaresällskapet (SLS-943288)
Stiftelsen Söderström-Königska (SLS-968742)
the Åke Wiberg Foundation
Karolinska Institute
- License Information
-
More Information
Article History
Received: 15 July 2025
Accepted: 12 February 2026
First Online: 26 February 2026
Declarations
:
: This study was approved by The Stockholm Regional Ethical Review Board (IRB approval number: Dnr 2020–06540). Informed consent was not required because it relied on registry data.
: No individual data is presented, and consent to publication is therefore not applicable.
: HL reports receiving grants from Shire Pharmaceuticals; personal fees from and serving as a speaker for Medice, Shire/Takeda Pharmaceuticals and Evolan Pharma AB; all outside the submitted work. HL is editor-in-chief of JCPP Advances. ML has received lecture honoraria from Lundbeck pharmaceuticals. All other authors have declared that they have no competing or potential conflicts of interest.
